Overall, we identified a peripheral Neuro-Endocrine-Immune pathway SNS/β-ARs/CCL2 in the eustress model to relieve tumor immunosuppression and to overcome PD-1 immunotherapy resistance. This evidence concerns the gene CTBP1 and neoplasm.